Clinical Trial: Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Brief Summary: The objective of this study is to prospectively evaluate the response of recombinant antithrombin (rAT) (ATRYN) in patients who are heparin resistant and are scheduled to undergo cardiac surgery.